🧾
Emergency information card
- Diagnosis and baseline labs.
- Hematologist/clinic phone.
- Medication and allergy list.
- Fever/bleeding/pain plan.
- Preferred hospital and transfusion requirements if applicable.
Resources that make care easier to understand.
Frequently asked questions, a hematology glossary, printable checklists, and launch-ready sections for contact and legal disclaimer.
FAQ
Frequently asked questions.
No. Iron deficiency is common, but anemia can also come from thalassemia, sickle cell disease, inflammation, hemolysis, kidney disease, vitamin deficiency, blood loss, marrow problems, or other causes. The CBC pattern, reticulocyte count, iron tests, smear, and history help distinguish causes.
Often yes, but activity limits depend on platelet count, bleeding symptoms, and the care team’s plan. Schools should know what to do for head injury or bleeding and which activities to avoid temporarily.
Some children are at higher risk of serious bacterial infection. Prompt evaluation and treatment can be lifesaving. Follow the fever plan from your child’s hematology team.
No. Hemophilia usually involves low factor VIII or IX and often causes joint or muscle bleeding. VWD involves von Willebrand factor and often causes nosebleeds, bruising, and heavy menstrual bleeding. Both require individualized bleeding plans.
Both can cause low platelets and red blood cell breakdown from small-vessel injury. TTP is often linked to very low ADAMTS13 activity and can have prominent neurologic symptoms. HUS often has kidney injury and may follow Shiga toxin diarrhea or be complement-mediated. Both can be emergencies.
No. It explains concepts and helps you ask better questions. Treatment must be chosen by your child’s clinician based on diagnosis, severity, age, labs, history, and local resources.
Glossary
Hematology words in plain language.
| Term | Meaning |
|---|---|
| Anemia | A lower-than-expected amount of hemoglobin or red blood cells. |
| ANC | Absolute neutrophil count, used to estimate bacterial/fungal infection-fighting capacity. |
| Antifibrinolytic | A medicine class that helps stabilize clots, often used for mouth, nose, or menstrual bleeding when prescribed. |
| Coagulation factors | Proteins in blood that work together to form stable clots. |
| Ferritin | A blood marker of iron storage, interpreted with clinical context. |
| Hemoglobinopathy | An inherited condition affecting hemoglobin, such as sickle cell disease or thalassemia. |
| Hemolysis | Red blood cells breaking down faster than normal. |
| HUS | Hemolytic uremic syndrome; a thrombotic microangiopathy often involving kidney injury. |
| ITP | Immune thrombocytopenia; immune-related low platelets. |
| MAHA | Microangiopathic hemolytic anemia; red cells are damaged in small blood vessels. |
| MCV | Mean corpuscular volume; average red blood cell size. |
| Neutropenia | Lower-than-expected neutrophils. |
| Petechiae | Tiny red-purple spots from small bleeds under the skin. |
| Platelets | Blood cells that help stop bleeding. |
| Reticulocytes | Young red blood cells that show marrow response. |
| TMA | Thrombotic microangiopathy; small-vessel clotting/injury pattern that includes TTP and HUS. |
| TTP | Thrombotic thrombocytopenic purpura; a rare emergency TMA often related to ADAMTS13 deficiency. |
| VWD | Von Willebrand disease; a bleeding disorder involving von Willebrand factor. |
Evidence base
Authoritative references for clinical review.
These external resources are included to support medical-director review and future content governance. Public launch should use locally approved pathways and the most current specialty guidance.
Content governance model
A professional medical website should separate education from clinical orders and document how content is reviewed.
Clinical owner: pediatric hematology
Legal/privacy review required
Protocol alignment required
Last review date: add before launch
Next review interval: 12 months or sooner
Recommended workflow: draft → pediatric hematologist review → nursing/ED workflow review → legal/privacy review → patient-family readability review → publication → scheduled audit.
Selected guideline and reference links
ASH 2019 Guidelines for Immune ThrombocytopeniaEvidence-based recommendations relevant to pediatric ITP evaluation and management.
ASH/ISTH/NHF/WFH 2021 VWD Management GuidelinesRecommendations for von Willebrand disease management, procedures, and bleeding scenarios.
WFH Guidelines for the Management of Hemophilia, 3rd editionComprehensive hemophilia care, prophylaxis, inhibitors, musculoskeletal health, and transition care.
ASH 2020 Sickle Cell Disease Cerebrovascular GuidelinesStroke screening and acute neurologic event recommendations.
CDC Sickle Cell Disease: FeverFamily-facing public health information on fever as a serious SCD complication.
ISTH TTP Guidelines HubDiagnostic and treatment guidance for thrombotic thrombocytopenic purpura and updates.
Hemolytic Uremic Syndrome in Children — ReviewOpen-access review covering pediatric HUS evaluation and management concepts.
NHLBI Iron-Deficiency Anemia Health TopicPatient and clinician-oriented overview of iron deficiency anemia.
Printables
Reusable care templates.
These are starter templates. Customize with your child’s medical team before use.
🏫
School communication note
- Condition overview.
- Activity or medication needs.
- Symptoms requiring parent call.
- Symptoms requiring emergency services.
- Attendance, hydration, bathroom, and rest accommodations.
📅
Follow-up tracker
- Next visit date.
- Labs to repeat.
- Medication changes.
- Questions for next visit.
- Vaccines, dental, procedure, or imaging reminders.
Contact demo
Request consult / appointment section.
This form is a front-end demo only. Before launch, connect it to a secure system that meets your local privacy and healthcare regulations.
Do not use forms for emergencies
Patients should call emergency services or go to the emergency department for urgent symptoms.
Medical disclaimer
Important limitations.
KidBloodCure.com is an educational website prototype. Content is not medical advice, diagnosis, treatment, a physician-patient relationship, or emergency service. Medical decisions must be made by qualified clinicians who can examine the child, review complete records, and apply local guidelines.
Before public launch, all medical content should be reviewed and approved by appropriately qualified pediatric hematology clinicians, legal/privacy advisors, and the responsible healthcare organization. Replace demo contact content with compliant workflows and region-specific emergency instructions.